Tomorrow Investor

IDEX Metals Expands Mineralized Footprint at Freeze Property with Discovery of New Breccia Zone and New Gold Zone

IDEX Metals Expands Gold Footprint with New Discovery | TheNewswire

Vancouver, B.C. – November 6th, 2025 – TheNewswire – IDEX Metals Corp. ( “IDEX” , or the “Company” ) (TSXV: IDEX; OTCQB: IDXMF) is pleased to report the discovery of a second mineralized breccia body (the “North Breccia” ) located 700 metres north of current drilling at the Kismet Breccia Complex ( “Kismet” ) on its 100%-owned Freeze Property in Idaho, USA ( “Freeze” , or the “Property” ). In addition, field crews have uncovered a new gold-bearing zone, (the “Frostfall Zone” ), approximately 950 metres further north. Key Highlights:

This excerpt is quoted from the original release. Read the full announcement on TheNewswire.

Brief Summary

IDEX Metals Corp. has achieved a significant milestone with the discovery of a new mineralized breccia body, the North Breccia, located just 700 metres from the Kismet Breccia Complex in its 100%-owned Freeze Property in Idaho. Additionally, the exploration team has identified a new gold-bearing zone, the Frostfall Zone, approximately 950 metres north, enhancing the potential of this promising area.

  • North Breccia identified 700 metres north of existing operations.
  • New gold-bearing zone named Frostfall Zone discovered.
  • Enhances the overall mineralized footprint of the Freeze Property.

Why it matters: This discovery could significantly boost IDEX’s resources, attracting investor interest and possibly leading to an increase in share value.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by TheNewswire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.